HK1030002A1 - Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same - Google Patents

Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same

Info

Publication number
HK1030002A1
HK1030002A1 HK01101003A HK01101003A HK1030002A1 HK 1030002 A1 HK1030002 A1 HK 1030002A1 HK 01101003 A HK01101003 A HK 01101003A HK 01101003 A HK01101003 A HK 01101003A HK 1030002 A1 HK1030002 A1 HK 1030002A1
Authority
HK
Hong Kong
Prior art keywords
production
pharmaceutical compositions
compositions containing
containing same
synthetic polysaccharides
Prior art date
Application number
HK01101003A
Other languages
English (en)
Inventor
Johannes Basten
Cornelia Dreef-Tromp
Pierre-Alexandre Driguez
Philippe Duchaussoy
Jean-Marc Herbert
Maurice Petitou
Constant Van Boeckel
Original Assignee
Sanofi Synthelabo
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo, Akzo Nobel Nv filed Critical Sanofi Synthelabo
Publication of HK1030002A1 publication Critical patent/HK1030002A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
HK01101003A 1998-01-19 2001-02-12 Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same HK1030002A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9800515A FR2773804B1 (fr) 1998-01-19 1998-01-19 Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
PCT/FR1999/000044 WO1999036443A1 (fr) 1998-01-19 1999-01-13 Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant

Publications (1)

Publication Number Publication Date
HK1030002A1 true HK1030002A1 (en) 2001-04-20

Family

ID=9521914

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01101003A HK1030002A1 (en) 1998-01-19 2001-02-12 Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same

Country Status (41)

Country Link
US (1) US6528497B1 (es)
EP (1) EP1049721B1 (es)
JP (1) JP4402835B2 (es)
KR (1) KR100513196B1 (es)
CN (1) CN1165550C (es)
AR (1) AR013019A1 (es)
AT (1) ATE209219T1 (es)
AU (1) AU741748B2 (es)
BR (1) BRPI9907025B8 (es)
CA (1) CA2317465C (es)
CO (1) CO4970795A1 (es)
CZ (1) CZ297815B6 (es)
DE (1) DE69900718T2 (es)
DK (1) DK1049721T3 (es)
DZ (1) DZ2709A1 (es)
EE (1) EE04157B1 (es)
EG (1) EG23982A (es)
ES (1) ES2168000T3 (es)
FR (1) FR2773804B1 (es)
GT (1) GT199900003A (es)
HK (1) HK1030002A1 (es)
HR (1) HRP20000480B1 (es)
HU (1) HU228333B1 (es)
IL (1) IL137241A0 (es)
MA (1) MA26597A1 (es)
MY (1) MY119090A (es)
NO (1) NO329903B1 (es)
NZ (1) NZ505492A (es)
PE (1) PE20000269A1 (es)
PL (1) PL202802B1 (es)
PT (1) PT1049721E (es)
RU (1) RU2211224C2 (es)
SA (1) SA99191113B1 (es)
SI (1) SI1049721T1 (es)
SK (1) SK283411B6 (es)
TR (1) TR200002078T2 (es)
TW (1) TW548279B (es)
UA (1) UA60352C2 (es)
UY (1) UY25356A1 (es)
WO (1) WO1999036443A1 (es)
ZA (1) ZA99355B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2814463B1 (fr) 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
FR2874924B1 (fr) 2004-09-09 2006-12-01 Sanofi Aventis Sa Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
IL188647A0 (en) * 2008-01-08 2008-11-03 Orina Gribova Adaptable structured drug and supplements administration system (for oral and/or transdermal applications)
WO2009130704A1 (en) * 2008-04-24 2009-10-29 Technion Research And Development Foundation Ltd. Beta-lactoglobulin-polysaccharide nanoparticles for hydrophobic bioactive compounds
US8614314B2 (en) 2008-05-30 2013-12-24 Momenta Pharmaceuticals, Inc. Saccharide structures and methods of making and using such structures
FR2935386B1 (fr) * 2008-08-26 2010-09-10 Sanofi Aventis Nouveaux polysaccharides a activite antithrombotique comprenant une liaion covalente avec une chaine amine
WO2010117803A2 (en) * 2009-03-30 2010-10-14 University Of Georgia Research Foundation, Inc. Heparan sulfate synthesis
BR112012000379A2 (pt) 2009-07-09 2016-03-29 Oshadi Drug Administration Ltd composições de matriz carreadora, métodos e usos
WO2011014793A2 (en) 2009-07-31 2011-02-03 Reliable Biopharmaceutical Corporation Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof
FR2949115B1 (fr) 2009-08-14 2012-11-02 Sanofi Aventis OLIGOSACCHARIDES N-SULFATES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2949114B1 (fr) 2009-08-14 2011-08-26 Sanofi Aventis OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
US8420790B2 (en) 2009-10-30 2013-04-16 Reliable Biopharmaceutical Corporation Efficient and scalable process for the manufacture of Fondaparinux sodium
EP2614089A1 (fr) 2010-09-10 2013-07-17 Sanofi-Aventis Polysaccharides biotinyles a activite antithrombotique et presentant une stabilite metabolique amelioree
US9005664B2 (en) 2010-10-17 2015-04-14 Technion Research And Development Foundation Ltd. Denatured lactoglobulin and polyphenol coassemblies
FR2970969B1 (fr) 2011-01-27 2013-10-18 Sanofi Aventis Oligosaccharides 3-o-alkyles activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260933A (en) * 1993-07-16 1996-07-26 Hercules Inc Cation-complexed polysaccharides; use in foods and pharmaceuticals
FR2749849B1 (fr) * 1996-06-14 1998-09-04 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
CZ427499A3 (cs) * 1998-05-29 2000-05-17 The Procter & Gamble Company Jemné topické antimikrobiální přípravky

Also Published As

Publication number Publication date
GT199900003A (es) 2000-07-07
BR9907025B1 (pt) 2013-12-10
CZ20002635A3 (cs) 2000-12-13
AR013019A1 (es) 2000-11-22
EP1049721A1 (fr) 2000-11-08
JP2002509164A (ja) 2002-03-26
SI1049721T1 (en) 2002-06-30
BR9907025A (pt) 2000-10-17
EE200000429A (et) 2001-12-17
AU741748B2 (en) 2001-12-06
WO1999036443A1 (fr) 1999-07-22
RU2211224C2 (ru) 2003-08-27
DZ2709A1 (fr) 2003-09-01
PT1049721E (pt) 2002-05-31
DE69900718D1 (de) 2002-02-21
MA26597A1 (fr) 2004-12-20
CA2317465C (en) 2008-05-20
DK1049721T3 (da) 2002-04-02
KR20010034189A (ko) 2001-04-25
EE04157B1 (et) 2003-10-15
PL341875A1 (en) 2001-05-07
EG23982A (en) 2008-02-27
UA60352C2 (uk) 2003-10-15
TW548279B (en) 2003-08-21
NO20003662L (no) 2000-09-14
NO329903B1 (no) 2011-01-24
SK10782000A3 (sk) 2001-02-12
CZ297815B6 (cs) 2007-04-04
HUP0102009A3 (en) 2003-07-28
HUP0102009A1 (hu) 2001-11-28
KR100513196B1 (ko) 2005-09-07
HRP20000480A2 (en) 2000-12-31
BRPI9907025B8 (pt) 2016-09-13
EE200000429A1 (et) 2003-06-16
FR2773804B1 (fr) 2000-02-18
MY119090A (en) 2005-03-31
TR200002078T2 (tr) 2000-11-21
UY25356A1 (es) 2000-10-31
PE20000269A1 (es) 2000-06-15
NZ505492A (en) 2001-12-21
CN1288470A (zh) 2001-03-21
NO20003662D0 (no) 2000-07-17
FR2773804A1 (fr) 1999-07-23
ES2168000T3 (es) 2002-05-16
US6528497B1 (en) 2003-03-04
HRP20000480B1 (en) 2002-04-30
ZA99355B (en) 2000-10-11
AU1974599A (en) 1999-08-02
CN1165550C (zh) 2004-09-08
DE69900718T2 (de) 2002-08-22
ATE209219T1 (de) 2001-12-15
JP4402835B2 (ja) 2010-01-20
SK283411B6 (sk) 2003-07-01
SA99191113B1 (ar) 2006-10-11
EP1049721B1 (fr) 2001-11-21
CO4970795A1 (es) 2000-11-07
IL137241A0 (en) 2001-07-24
HU228333B1 (en) 2013-03-28
CA2317465A1 (en) 1999-07-22
PL202802B1 (pl) 2009-07-31

Similar Documents

Publication Publication Date Title
PL380081A1 (pl) Pochodne 3,3-difenylopropyloamin, sposoby ich wytwarzania, kompozycja farmaceutyczna oraz zastosowania
IL136951A0 (en) Sustained-release composition, method of its production and use thereof
PL345040A1 (en) Novel acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same
IL119488A0 (en) Substituted 2,4-imidazolidinediones their production and pharmaceutical compositions containing them
HUP9802422A3 (en) Substituted isoquinoline-3-carboxamide derivatives, process for producing them and pharmaceutical compositions containing them
HUP0101599A3 (en) Heterocyclically substituted amides, process for producing them, use of them and pharmaceutical compositions containing them
HUP9900120A3 (en) Benzosulfone derivatives, process for producing them and pharmaceutical compositions containing them
HK1030002A1 (en) Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same
HU9802653D0 (en) Substituted imidazolidine derivatives, process for producing them, their use, and pharmaceutical compositions containing them
HUP9902287A3 (en) Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same
HUP9901616A3 (en) Novel benzofuranone derivatives, process for their production and pharmaceutical compositions of the same
HK1039122A1 (zh) 取代的6-苄基-4-氧代嘧啶,其製備方法以及含該化合物的藥物組合物
HK1029999A1 (en) New pentasaccharides, their methods of production and pharmaceutical compositions containing same
HUP9700955A3 (en) Substituted 2-naphtoylguanidine derivatives, their production, and pharmaceutical compositions containing them
HUP0103316A3 (en) 2-ureido-pyrimidone derivatives, method for producing them, pharmaceutical compositions containing them and their use
PL311257A1 (en) New compounds and method of their production as well as pharmaceutical compounds and method of its production
HUP0004663A3 (en) Substituted isoquinoline derivatives, process for producing them and use of them for producing pharmaceutical compositions as anticonvulsants and pharmaceutical compositions containing them
IL139531A0 (en) Human antithrombin iii, methods for the production thereof and pharmaceutical compositions containing the same
PL342453A1 (en) Biphenylsulphonylcyanamides, method of obtaining them and their application as drugs
EP1059304A4 (en) NOVEL POLYSACCHARIDE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITIONS CONTAINING THESE NEW DERIVATIVES AS ACTIVE INGREDIENT
HUP9700954A3 (en) Substituted 1-naphtoylguanidine derivatives, their production, and pharmaceutical compositions containing them
HUP9700437A3 (en) Guanidino-derivatives of substituted thienyl-alkenyl-carboxylic-acids, their production, and pharmaceutical compositions containing them
HUP9904564A3 (en) Substituted aminomethyl-cycloheptenes, process for producing them, their use, and pharmaceutical compositions containing them
HUP0103204A3 (en) New 4-amino-1-aryl-pyridine-2-ones with anticonvulsive action and method for producing same, their use and pharmaceutical compositions containing them
AU695490B2 (en) 6-methoxy-1h-benzotriazole-5-carboxamide derivatives, their production processes and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
AS Change of ownership

Owner name: SANOFI-SYNTHELABO

Free format text: FORMER OWNER(S): SANOFI-SYNTHELABO, AKZO NOBEL N.V

PF Patent in force
CHPA Change of a particular in the register (except of change of ownership)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180113